Literature DB >> 22706705

Polymorphic lymphoid proliferations occurring in HIV-positive patients: report of a case responding to HAART.

Jenny Buxton1, Clifford Leen, John R Goodlad.   

Abstract

Epstein-Barr virus (EBV)-associated polymorphic lymphoid proliferations resembling polymorphic post-transplant lymphoproliferative disorders are a rare but recognised complication of the human immunodeficiency virus (HIV). These account for fewer than 5 % of HIV-associated lymphomas, and little information has been published regarding their treatment and outcome. Of the reported cases, many have presented with extranodal disease, not typical of lymphoma. We report the case of a patient presenting with lung infiltrates shown to be the result of an EBV-associated polymorphic lymphoproliferation resembling a polymorphic post-transplant lymphoproliferative disorder. The patient was simultaneously found to be HIV positive and commenced on highly active antiretroviral therapy. Without any specific anti-neoplastic treatment, the patient recovered completely and within 20 months had no symptoms or radiological evidence of a lymphoproliferative disorder. This illustrates the importance of recognising this uncommon condition in HIV-positive patients and avoiding potentially unnecessary chemotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 22706705     DOI: 10.1007/s00428-012-1261-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

1.  Polymorphic lymphoid proliferation presenting as ileocecal intussusception.

Authors:  Xi Wang; Sunita Nathan; Rosalind Catchatourian; Harry Richter; Paula Kovarik
Journal:  Ann Hematol       Date:  2007-01-10       Impact factor: 3.673

2.  Prognosis in HIV-associated malignancies #214.

Authors:  Steven Oppenheim
Journal:  J Palliat Med       Date:  2009-09       Impact factor: 2.947

Review 3.  Spectrum of HIV lymphoma 2009.

Authors:  Ayca Gucalp; Ariela Noy
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

4.  A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy.

Authors:  Haruyuki Fujita; Momoko Nishikori; Akifumi Takaori-Kondo; Noriyoshi Yoshinaga; Yoshiaki Ohara; Takayuki Ishikawa; Hironori Haga; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2010-03-10       Impact factor: 2.490

Review 5.  Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.

Authors:  Stanley I Martin; Lawrence Zukerberg; Gregory K Robbins
Journal:  Clin Infect Dis       Date:  2005-09-09       Impact factor: 9.079

Review 6.  Antitumour effects of antiretroviral therapy.

Authors:  Paolo Monini; Cecilia Sgadari; Elena Toschi; Giovanni Barillari; Barbara Ensoli
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders.

Authors:  Roland G Nador; Amy Chadburn; Girija Gundappa; Ethel Cesarman; Jonathan W Said; Daniel M Knowles
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

8.  Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a child with acquired immunodeficiency syndrome.

Authors:  D W Kingma; B U Mueller; K Frekko; L R Sorbara; L V Wood; D Katz; M Raffeld; E S Jaffe
Journal:  Arch Pathol Lab Med       Date:  1999-01       Impact factor: 5.534

9.  Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.

Authors:  Christian Hoffmann; Eva Wolf; Gerd Fätkenheuer; Thomas Buhk; Albrecht Stoehr; Andreas Plettenberg; Hans-Jürgen Stellbrink; Hans Jaeger; Uwe Siebert; Heinz-August Horst
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

Review 10.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

View more
  3 in total

1.  Successful treatment of an EBV-positive HIV-associated polymorphic B-cell lymphoproliferative disorder by rituximab monotherapy.

Authors:  Mohamad Sabbah; Sylvain Choquet; Agathe Maillon; Clotilde Bravetti; Marine Baron; Frédéric Charlotte; Damien Roos-Weil
Journal:  EJHaem       Date:  2021-06-05

2.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

3.  A Rare Case of Three Distinct Epstein-Barr Virus Associated Lymphoproliferative Disorders Over Sixteen Years of Human Immunodeficiency Virus Infection.

Authors:  Hamdy M A Ahmed; Abrar Khan; Weyman Lam; Samar Abohamad; Pradyumna Phatak
Journal:  Hematol Rep       Date:  2017-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.